Who are Glycerin ear drops's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Hypertonic saline 3% bolus administration, Mannitol Inhalation Kit, Sodium Chloride [3%], NaCl 7.5%, Hypertonic Saline 7%, Saline solution, 0.6%.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/glycerin-ear-drops.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Glycerin ear drops — Competitive Intelligence Brief

Glycerin ear drops (Glycerin ear drops) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic agent. Area: Otolaryngology.

phase 3 Osmotic agent Otolaryngology Small molecule Live · refreshed every 30 min

Target snapshot

Glycerin ear drops (Glycerin ear drops) — Arbor Pharmaceuticals, Inc.. Glycerin ear drops work by drawing fluid out of the middle ear through osmotic action, reducing pressure and relieving ear discomfort.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Glycerin ear drops TARGET	Glycerin ear drops	Arbor Pharmaceuticals, Inc.	phase 3	Osmotic agent
Hypertonic saline 3% bolus administration	Hypertonic saline 3% bolus administration	Université de Sherbrooke	marketed	Osmotic agent
Mannitol Inhalation Kit	Mannitol Inhalation Kit	Dr. Diane Lougheed	marketed	Osmotic agent / Airway clearance therapy
Sodium Chloride [3%]	Sodium Chloride [3%]	Fundacion Clinica Valle del Lili	marketed	Electrolyte solution / Osmotic agent
NaCl 7.5%	NaCl 7.5%	Aristotle University Of Thessaloniki	marketed	Osmotic agent / Electrolyte solution
Hypertonic Saline 7%	Hypertonic Saline 7%	The Hospital for Sick Children	marketed	Osmotic agent
Saline solution, 0.6%	Saline solution, 0.6%	Novaliq GmbH	marketed	Osmotic agent / Ophthalmic decongestant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic agent class)

Arbor Pharmaceuticals, Inc. · 1 drug in this class
Innogene Kalbiotech Pte. Ltd · 1 drug in this class
Medical University of Silesia · 1 drug in this class
Seref istek · 1 drug in this class
The Hospital for Sick Children · 1 drug in this class
Université de Sherbrooke · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Glycerin ear drops — Competitive Intelligence Brief. https://druglandscape.com/ci/glycerin-ear-drops. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab